Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Mei Baker, MD, Wisconsin State Laboratory of Hygiene (WSLH) Newborn Screening Laboratory co-director and University of Wisconsin associate professor of pediatrics, received the Harry Hannon Laboratory Improvement Award in Newborn Screening from the Association of Public Health Laboratories (APHL) earlier this month at the National Newborn Screening and Genetics Symposium. The award is named after Dr. Harry Hannon, the long-time director …
Giizhik Klawiter has autism and began drawing at six years old as a therapeutic outlet. For the last five years, Giizhik and his brother Mino have designed holiday greeting cards and sold them in their hometown of Hayward, Wisconsin with the help of their mother, Pam Miller. The colorful and unique cards provide an opportunity …
When Madison attorney David Walsh learned 17 years ago that his sons have a genetic disorder that causes blindness, he went into action mode.
Living Our Visions (LOV)-Dane, based at the Waisman Center’s satellite community outreach office in Madison, is a grassroots organization of individuals with disabilities, their families and community members who strive to create fulfilling, community-centered lives for adults with disabilities. By mobilizing its members’ strengths, LOV-Dane focuses on the assets of people with disabilities, and works to …
Variation among preterm infants is the norm One in 10 infants in the United States is born preterm—less than 36 weeks gestation—each year. Infants born early are at a higher risk for long-term health problems and neurodevelopmental and cognitive delays. According to a new study that followed preterm infants in Wisconsin, not all premature infants …
A recent issue of The Why Files features stem advances at the University of Wisconsin-Madison, including several scientists at the Waisman Center.
The UW Madison’s Waisman Center maintains its status as a world class center dedicated to advancing knowledge about human development, developmental disabilities and neurodegenerative diseases through research, teaching and service. It is exceedingly successful in all three areas, and is just as successful in a fourth area: community outreach. This coming Saturday the Waisman Center …
A rare disease can be isolating when few people have it and there is no cure.
John Svaren, PhD’s paper “Genome editing-enabled HTS assays expand drug target pathways for Charcot-Marie-Tooth disease,” examines how the use of genome editing places his research one step closer to a potential cure for Charcot-Marie-Tooth disease.
The link between a protein typically associated with Alzheimer’s disease and its impact on memory and cognition may not be as clear as once thought, according to a new study from the University of Wisconsin–Madison’s Waisman Center. The findings are revealing more information about the earliest stages of the neurodegenerative disease. The researchers — including …
